Therapeutically exploiting non-oncogene addiction and defining genetic interactions for disease progression in a preclinical model of inflammation-dependent gastric tumourigenesis [ 2011 - 2014 ]

Also known as: Testing therapeutics in a preclinical gastric cancer model and defining the underlying genetics of cancer progression

Research Grant

[Cite as]

Researchers: Prof Matthias Ernst (Principal investigator)

Brief description Cancers of the stomach are often associated with chronic inflammation and represent a major health burden with little treatment options available. We propose to test whether drugs undergoing clinical testing for other diseases may have beneficial effects in a preclinical model of gastric cancer, and establish the genetic interaction required for gastric cancer progression. The study outcomes may highlight novel therapeutic opportunities for the clinic.

Funding Amount $AUD 624,960.70

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]